SLDB Solid Biosciences Inc. - Common Stock
NASDAQ · Biotechnology · SEC EDGAR'da Görüntüle ↗ kapat Eki 2, 2026 10-K/10-Q Ağu 6, 2026
$6,85
· 52 haftalık aralığın %'i
· düşüğün üstünde
· yükseğe
$3,7952 haftanın en düşüğü
$11,4552 haftanın en yükseği
Piyasa Değeri (MRQ)
$720M
P/E
-3.4
Hisse Başına Kâr
$-1.99
rozetleriniz
52 Haftlık Aralık
$4–$11
Analist Derecelendirmesi
BUY
Fiyat Hedefi
$19
P/E
-3.4
ROE
-79.5%
Net Kâr Marjı
·
Rozet şeridiniz boş — bu sayfada herhangi bir metriği sabitleyin.
SLDB Hisse Senedi Özeti Fiyat, piyasa değeri, P/E, EPS, ROE, borç/öz sermaye, 52 haftalık aralık
Fiyat
$6.85
Piyasa Değeri (MRQ)
$720M
P/E
-3.4
Hisse Başına Kâr
$-1.99
ROE
-79.5%
52 Haftlık Aralık
$4–$11
SLDB Hisse Senedi Fiyat Grafiği Teknik göstergeler ile günlük OHLCV — kaydır, yakınlaştır ve görünümünüzü özelleştirin
aralık
çubuklar
Çubuk çözünürlüğü seçilen döneme uyum sağlar — bir çubuk için açılış/yüksek/düşük/kapanış değerlerini görmek için grafiğin üzerine gelin.
Hisse bölünmeleri
| Ex-tarihi | Bölünme | Tür |
|---|---|---|
| 28 Ekim 2022 | 1-for-15 | Ters |
10 Yıllık Performans Gelir, net kar, marjlar ve EPS trendleri
Gelir·2016-12-31 → 2022-12-31
Hisse Başına Kâr$-1.992020-12-31 → 2025-12-31
Serbest Nakit Akışı$-157M2018-12-31 → 2025-12-31
Net kar marjı·2021-12-31 → 2022-12-31
Değerleme ve Oranlar
Değerleme P/E, P/S, P/B, EV/EBITDA oranları — hisse senedi pahalı mı ucuz mu?
| Metrik | 5 Yıllık trend | SLDB | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| P/E | -3.45Y ort. ≈-1.7 | ≈-1.7 | · | · | |
| F/D (MRQ) | 1.95Y ort. ≈3.8 | ≈3.8 | 3.2 | Adil değer | |
| Fiyat / Serbest Nakit Akışı (TTM) | -3.85Y ort. ≈-8.7 | ≈-8.7 | · | · | |
| Fiyat / Nakit Akışı (TTM) | -3.95Y ort. ≈-8.8 | ≈-8.8 | · | · | |
| Price / Tangible Book (Fiyat / Maddi Defter Değeri) | 3.05Y ort. ≈3.8 | ≈3.8 | · | · |
Akran ortalaması, metrik başına standartlaştırılmış bir temelde hesaplanır ve bu hisse senedi için gösterilen TTM/MRQ temelini her zaman eşleşmeyebilir.
Kârlılık Brüt, faaliyet ve net kâr marjları; ROE, ROA, ROIC
| Metrik | 5 Yıllık trend | SLDB | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| ROA | -82.8%5Y ort. ≈-53.8% | ≈-53.8% | -46.1% | Zayıf | |
| ROE | -79.5%5Y ort. ≈-62.9% | ≈-62.9% | -53.7% | Zayıf | |
| ROIC | -99.6% | · | -34.2% | Zayıf |
Finansal Sağlık Borç, likidite, solventlik — bilanço gücü
| Metrik | 5 Yıllık trend | SLDB | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| Cari Oran (MRQ) | 13.85Y ort. ≈7.9 | ≈7.9 | 14.4 | Aynı seviyede | |
| Quick Ratio (Cari Oran) | 1.85Y ort. ≈4.3 | ≈4.3 | 6.6 | Aynı seviyede |
Büyüme Gelir, EPS ve net gelir büyümesi: YOY, 3 Yıllık CAGR, 5 Yıllık CAGR
Bu oran grubu için henüz veri yok
Bu oran grubunu hesaplamak için henüz yeterli temel veriye sahip değil.
Sermaye Verimliliği Aktif devir hızı, stok devir hızı, alacak devir hızı
Bu oran grubu için henüz veri yok
Bu oran grubunu hesaplamak için henüz yeterli temel veriye sahip değil.
değer · ≈ 5Y ort. · sektör ortalaması · ortalamaya göre değerlendirme
Kazanç Geçmişi EPS gerçekleşen vs tahmin, sürpriz %, kazanma oranı, bir sonraki kazanç tarihi
Ort. Sürpriz
-1.7%
Sonraki Rapor
Kas 02, 2026
| Dönem | Rapor | EPS Gerçek | EPS Tahmin | Sürpriz |
|---|---|---|---|---|
| 30 Haziran 2026 | Ağu 10, 2026 | $-0.38 | $-0.48 | 20.4% |
| 31 Mart 2026 | May 13, 2026 | $-0.52 | $-0.44 | -17.6% |
| 31 Aralık 2025 | $-0.53 | $-0.53 | -0.15% | |
| 30 Eylül 2025 | $-0.48 | $-0.45 | -7.3% | |
| 30 Haziran 2025 | $-0.42 | $-0.51 | 18.3% | |
| 31 Mart 2025 | $-0.59 | $-0.57 | -4.1% | |
| 31 Aralık 2024 | $-1.00 | $-0.82 | -21.6% |
Tüm Temeller Tüm metrikler yıla göre — gelir tablosu, bilanço, nakit akışı
Gelir Tablosu
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | · | · | · | $8M | $14M | $0 | $0 | $0 | $0 | |
| R&D Expense | $140M | $96M | $77M | $78M | $59M | $65M | $95M | $58M | $40M | |
| SG&A Expense | $39M | $33M | $28M | $29M | $27M | $22M | $25M | $18M | $15M | |
| Operating Expenses | $179M | $130M | $104M | $115M | $86M | $88M | $119M | $76M | $55M | |
| Operating Income | $-179M | $-130M | $-104M | $-106M | $-72M | $-88M | $-119M | $-76M | $-55M | |
| Interest Income | $10M | $9M | $8M | $3M | $64.0K | $115.0K | $2M | $619.0K | $219.0K | |
| Other Non-op | $824.0K | $652.0K | $1M | $-381.0K | $2.0K | $1.0K | $515.0K | $270.0K | $1M | |
| Pretax Income | $-174M | $-125M | · | · | · | · | · | · | · | |
| Income Tax | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | · | |
| Net Income | $-174M | $-125M | $-96M | $-86M | $-72M | $-88M | $-117M | $-75M | $-52M | |
| EPS (Basic) | $-1.99 | $-3.06 | $-4.83 | $-10.10 | $-10.14 | $-25.50 | · | · | · | |
| EPS (Diluted) | $-1.99 | $-3.06 | $-4.83 | $-10.10 | $-10.14 | $-25.50 | · | · | · | |
| Shares (Basic) | 87,504,631 | 40,816,694 | 19,884,007 | 8,512,089 | 7,118,024 | 3,462,475 | · | · | · | |
| Shares (Diluted) | 87,504,631 | 40,816,694 | 19,884,007 | 8,512,089 | 7,118,024 | 3,462,475 | · | · | · | |
| EBITDA | $-179M | $-130M | $-104M | $-106M | $-72M | $-88M | · | $-76M | · |
Bilanço
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $60M | $80M | $74M | $155M | $119M | $155M | $76M | $86M | $52M | |
| Short-term Investments | · | · | · | · | · | · | · | $36M | $17M | |
| Prepaid Expense | $16M | $8M | $6M | $6M | $15M | $4M | $3M | $6M | $1M | |
| Current Assets | $205M | $157M | $130M | $220M | $223M | $159M | $86M | $129M | $71M | |
| PP&E (Net) | $4M | $5M | $7M | $10M | $6M | $8M | $12M | $10M | $2M | |
| PP&E (Gross) | $18M | $18M | $19M | $21M | $18M | $17M | $16M | $12M | $3M | |
| Accum. Depreciation | $14M | $13M | $13M | $11M | $12M | $9M | $5M | $2M | $504.0K | |
| Other Non-current Assets | $223.0K | $366.0K | $209.0K | $175.0K | $94.0K | $209.0K | $209.0K | $209.0K | · | |
| Total Assets | $233M | $189M | $165M | $260M | $232M | $171M | $103M | $140M | $76M | |
| Accounts Payable | $3M | $4M | $2M | $3M | $4M | $3M | $7M | $4M | $5M | |
| Accrued Liabilities | $19M | $20M | $10M | $17M | $10M | $9M | $9M | $8M | $6M | |
| Current Liabilities | $33M | $30M | $15M | $23M | $24M | $24M | $18M | $12M | $11M | |
| Capital Leases | $19M | $21M | $23M | $24M | $275.0K | $2M | $4M | $859.0K | · | |
| Other Non-current Liabilities | · | · | · | $96.0K | · | $1M | · | $1M | · | |
| Total Liabilities | $53M | $51M | $38M | $49M | $24M | $39M | $23M | $14M | $11M | |
| Common Stock | $79.0K | $40.0K | $20.0K | $20.0K | $7.0K | $87.0K | $48.0K | $35.0K | · | |
| Retained Earnings | $-958M | $-783M | $-659M | $-563M | $-477M | $-405M | $-316M | $-199M | $-124M | |
| AOCI | $52.0K | $47.0K | $15.0K | $-68.0K | $-45.0K | $0 | $1.0K | $-5.0K | $-13.0K | |
| Stockholders' Equity | $180M | $137M | $126M | $212M | $208M | $132M | $80M | $125M | $-59M | |
| Liabilities + Equity | $233M | $189M | $165M | $260M | $232M | $171M | $103M | $140M | $76M | |
| Shares Outstanding | 78,967,888 | 40,468,141 | 20,386,606 | 19,556,732 | 7,356,017 | 84,893,994 | 45,987,571 | 35,432,460 | 0 |
Nakit Akışı
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $2M | $2M | $3M | $2M | $3M | $4M | $3M | · | · | |
| Stock-based Comp | $17M | $11M | $8M | $8M | $13M | $12M | $14M | $6M | $5M | |
| Restructuring | · | · | $-63.0K | $7M | · | $2M | · | · | · | |
| Operating Cash Flow | $-156M | $-100M | $-94M | $-98M | $-78M | $-57M | $-93M | $-70M | $-43M | |
| CapEx | $1M | $654.0K | $2M | $3M | $1M | $899.0K | $4M | $8M | $2M | |
| Investing Cash Flow | $-58M | $-16M | $10M | $59M | $-91M | $7M | $25M | $-27M | $10M | |
| Stock Issued | · | · | $3M | $73M | $135M | $113M | $49M | · | · | |
| Net Stock Activity | · | · | $3M | $73M | $135M | $113M | · | · | · | |
| Financing Cash Flow | $194M | $122M | $3M | $75M | $135M | $129M | $58M | $132M | $77M | |
| Net Change in Cash | $-20M | $6M | $-81M | $36M | $-34M | $79M | $-10M | $35M | $44M | |
| Free Cash Flow | $-157M | $-101M | $-96M | $-101M | $-79M | $-57M | · | $-78M | · |
Kârlılık
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | · | · | · | -1315.2% | -530.5% | · | · | · | · | |
| Net Margin | · | · | · | -1062.3% | -530.0% | · | · | · | · | |
| EBITDA Margin | · | · | · | -1315.2% | -530.5% | · | · | · | · | |
| ROA | -82.8% | -70.5% | -45.2% | -34.9% | -35.8% | -64.3% | · | -69.3% | · | |
| ROE | -79.5% | -82.0% | -70.9% | -48.4% | -33.5% | -114.4% | · | -55.4% | · | |
| ROIC | -99.6% | · | · | · | · | · | · | · | · |
Likidite ve Solventlik
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 6.1 | 5.2 | 8.9 | 9.8 | 9.4 | 6.5 | · | 10.3 | · | |
| Quick Ratio | 1.8 | 2.7 | 5.1 | 6.9 | 5.0 | 6.3 | · | 6.9 | · |
Verimlilik
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | · | · | 0.0 | 0.1 | 0.0 | · | 0.0 | · |
Hisse Başına
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $2.28 | $3.39 | $6.20 | $10.82 | $1.89 | $1.56 | · | $3.53 | · | |
| Revenue / Share | · | · | · | $0.95 | · | · | · | · | · | |
| Cash Flow / Share | $-1.79 | $-2.45 | $-4.74 | $-11.51 | · | · | · | · | · | |
| Cash / Share | $0.76 | $1.98 | $3.63 | $7.95 | $1.08 | $1.82 | · | $2.44 | · | |
| EPS (TTM) | $-1.99 | $-3.06 | $-4.83 | $-10.10 | $-10.14 | $-25.50 | · | · | · |
Büyüme Oranları
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | · | · | · | -40.6% | · | · | · | · | · |
Değerleme (TTM)
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $0 | $0 | $0 | $8M | $14M | $0 | $0 | $0 | $0 | |
| Net Income TTM | $-174M | $-125M | $-96M | $-86M | $-72M | $-88M | $-117M | $-75M | $-52M | |
| Market Cap | $445M | $162M | $125M | $105M | $2.90B | $9.65B | · | $14.24B | · | |
| P/E | -2.8 | -1.3 | -1.3 | -0.5 | -2.6 | -4.5 | · | · | · | |
| P/S | · | · | · | 13.0 | 212.7 | · | · | · | · | |
| P/B | 2.5 | 1.2 | 1.0 | 0.5 | 13.9 | 73.1 | · | 113.8 | · | |
| P / Tangible Book | 2.5 | 1.2 | 1.0 | 0.5 | 13.9 | 73.1 | · | · | · | |
| P / Cash Flow | -2.8 | -1.6 | -1.3 | -1.1 | -37.2 | -170.5 | · | -202.9 | · | |
| P / FCF | -2.8 | -1.6 | -1.3 | -1.0 | -36.6 | -167.9 | · | -182.7 | · | |
| Earnings Yield | -35.3% | -76.5% | -78.7% | -187.7% | -38.6% | -22.4% | · | · | · |
Gelir Tablosu
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expense | $44M | $46M | $38M | $39M | $32M | $31M | $31M | $27M | $19M | $19M | $15M | $17M | $20M | $25M | $21M | $14M | |
| SG&A Expense | $13M | $11M | $11M | $9M | $9M | $9M | $9M | $8M | $8M | $8M | $7M | $6M | $7M | $7M | $8M | $7M | |
| Operating Expenses | $57M | $57M | $49M | $48M | $42M | $40M | $40M | $35M | $28M | $27M | $22M | $23M | $27M | $32M | $35M | $21M | |
| Operating Income | $-57M | $-57M | $-49M | $-48M | $-42M | $-40M | $-40M | $-35M | $-28M | $-27M | $-22M | $-23M | $-27M | $-32M | $-35M | $-21M | |
| Interest Expense | · | · | · | · | · | · | · | · | $88.0K | $95.0K | · | · | $111.0K | $121.0K | · | · | |
| Interest Income | $3M | $2M | $2M | $3M | $3M | $2M | $2M | $2M | $3M | $3M | $2M | $2M | $2M | $2M | $2M | $735.0K | |
| Other Non-op | $214.0K | $157.0K | $219.0K | $210.0K | $207.0K | $188.0K | $199.0K | $211.0K | $239.0K | $3.0K | $270.0K | $278.0K | $265.0K | $282.0K | $-355.0K | $-13.0K | |
| Income Tax | · | · | · | · | · | · | · | · | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Net Income | $-55M | $-57M | $-50M | $-46M | $-39M | $-39M | $-43M | $-33M | $-25M | $-24M | $-20M | $-21M | $-25M | $-30M | $-15M | $-20M | |
| EPS (Basic) | $-0.38 | $-0.52 | $-0.50 | $-0.48 | $-0.42 | $-0.59 | $-1.02 | $-0.79 | $-0.61 | $-0.64 | $-0.99 | $-1.05 | $-1.25 | $-1.54 | $-0.69 | $-2.71 | |
| EPS (Diluted) | $-0.38 | $-0.52 | $-0.67 | $-0.48 | $-0.42 | $-0.59 | $-1.02 | $-0.79 | $-0.61 | $-0.64 | $-0.99 | $-1.05 | $-1.25 | $-1.54 | $-0.69 | $-2.71 | |
| Shares (Basic) | 143,688,701 | 109,811,461 | · | 94,417,746 | 94,140,286 | 66,341,305 | · | 41,443,317 | 40,934,361 | 38,155,373 | · | 20,059,641 | 19,663,672 | 19,567,635 | · | 7,532,706 | |
| Shares (Diluted) | 143,688,701 | 109,811,461 | · | 94,417,746 | 94,140,286 | 66,341,305 | · | 41,443,317 | 40,934,361 | 38,155,373 | · | 20,059,641 | 19,663,672 | 19,567,635 | · | 7,532,706 | |
| EBITDA | $-57M | $-57M | · | $-48M | $-42M | $-40M | · | $-35M | $-28M | $-27M | · | $-23M | $-27M | $-32M | · | $-21M |
Bilanço
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $159M | $297M | $60M | $61M | $139M | $211M | $80M | $64M | $96M | $118M | $74M | $49M | $92M | $165M | $155M | $49M | |
| Prepaid Expense | $17M | $15M | $16M | $9M | $11M | $6M | $8M | $8M | $7M | $8M | $6M | $5M | $7M | $5M | $6M | $5M | |
| Current Assets | $395M | $397M | $205M | $245M | $279M | $313M | $157M | $179M | $198M | $214M | $130M | $148M | $167M | $191M | $220M | $148M | |
| PP&E (Net) | $4M | $4M | $4M | $4M | $4M | $4M | $5M | $5M | $5M | $6M | $7M | $7M | $7M | $9M | $10M | $6M | |
| PP&E (Gross) | · | · | $18M | · | · | · | $18M | · | · | $19M | $19M | $19M | $19M | $19M | $21M | $16M | |
| Accum. Depreciation | · | · | $14M | · | · | · | $13M | · | · | $13M | $13M | $12M | $12M | $11M | $11M | $9M | |
| Other Non-current Assets | $138.0K | $183.0K | $223.0K | $247.0K | $278.0K | $319.0K | $366.0K | $475.0K | $515.0K | $175.0K | $209.0K | $315.0K | $181.0K | $238.0K | $175.0K | $422.0K | |
| Total Assets | $421M | $423M | $233M | $274M | $308M | $344M | $189M | $212M | $231M | $249M | $165M | $185M | $205M | $230M | $260M | $184M | |
| Accounts Payable | $4M | $6M | $3M | $8M | $5M | $6M | $4M | $3M | $3M | $2M | $2M | $2M | $3M | $6M | $3M | $5M | |
| Accrued Liabilities | $18M | $19M | $19M | $19M | $17M | $15M | $20M | $13M | $10M | $10M | $10M | $11M | $11M | $12M | $17M | $10M | |
| Current Liabilities | $29M | $30M | $33M | $36M | $30M | $29M | $30M | $23M | $15M | $14M | $15M | $16M | $16M | $20M | $23M | $17M | |
| Capital Leases | $18M | $18M | $19M | $20M | $20M | $21M | $21M | $22M | $22M | $23M | $23M | $23M | $24M | $24M | $24M | $24M | |
| Other Non-current Liabilities | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $96.0K | · | |
| Total Liabilities | $47M | $49M | $53M | $56M | $50M | $49M | $51M | $45M | $38M | $38M | $38M | $40M | $41M | $46M | $49M | $41M | |
| Common Stock | $105.0K | $98.0K | $79.0K | $78.0K | $78.0K | $77.0K | $40.0K | $39.0K | $39.0K | $38.0K | $20.0K | $20.0K | $20.0K | $20.0K | $20.0K | $8.0K | |
| Retained Earnings | $-1.07B | $-1.01B | $-958M | $-908M | $-862M | $-823M | $-783M | $-741M | $-708M | $-683M | $-659M | $-638M | $-617M | $-593M | $-563M | $-548M | |
| AOCI | $-113.0K | $-13.0K | $52.0K | $48.0K | $-38.0K | $2.0K | $47.0K | $116.0K | $-15.0K | $-4.0K | $15.0K | $2.0K | $14.0K | $5.0K | $-68.0K | $-196.0K | |
| Stockholders' Equity | $374M | $374M | $180M | $218M | $258M | $294M | $137M | $167M | $193M | $211M | $126M | $144M | $164M | $184M | $212M | $143M | |
| Liabilities + Equity | $421M | $423M | $233M | $274M | $308M | $344M | $189M | $212M | $231M | $249M | $165M | $185M | $205M | $230M | $260M | $184M | |
| Shares Outstanding | 105,125,366 | 98,394,720 | 78,967,888 | 77,882,685 | 77,602,741 | 77,492,959 | 40,468,141 | 38,930,203 | 38,551,059 | 37,833,689 | 20,386,606 | 20,061,751 | 20,044,389 | 19,573,132 | 19,556,732 | 7,533,081 |
Nakit Akışı
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $391.0K | $395.0K | $467.0K | $376.0K | $386.0K | $407.0K | $488.0K | $405.0K | $1M | $327.0K | · | · | · | · | · | · | |
| Stock-based Comp | $6M | $5M | $6M | $4M | $3M | $3M | $4M | $3M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | |
| Restructuring | · | · | · | · | · | · | · | · | · | · | $0 | $0 | $-63.0K | · | $6M | $0 | |
| Operating Cash Flow | $-53M | $-47M | $-54M | $-33M | $-37M | $-32M | $-30M | $-24M | $-21M | $-25M | $-21M | $-18M | $-27M | $-28M | $-34M | $-20M | |
| CapEx | $150.0K | $165.0K | $565.0K | $85.0K | $377.0K | $126.0K | $204.0K | $15.0K | $286.0K | $149.0K | $90.0K | $383.0K | $536.0K | $506.0K | $856.0K | $839.0K | |
| Investing Cash Flow | $-134M | $45M | $47M | $-45M | $-33M | $-27M | $39M | $-11M | $-5M | $-38M | $45M | $-25M | $-48M | $37M | $66M | $15M | |
| Stock Issued | · | · | · | · | · | · | · | · | · | · | · | $0 | · | · | · | · | |
| Financing Cash Flow | $48M | $239M | $5M | $1M | $-2M | $190M | $7M | $3M | $5M | $107M | $505.0K | $0 | · | · | $75M | $-1.0K | |
| Net Change in Cash | $-138M | $237M | $-1M | $-78M | $-72M | $130M | $16M | $-31M | $-22M | $44M | $25M | $-43M | $-73M | $9M | $106M | $-6M | |
| Free Cash Flow | · | $-47M | · | · | · | $-32M | · | · | · | $-25M | · | · | · | $-29M | · | · |
Kârlılık
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | -15.0% | -14.8% | · | -18.9% | -14.6% | -13.3% | · | -16.5% | -11.5% | -10.2% | · | -11.4% | -11.9% | -13.8% | · | -9.4% | |
| ROE | -17.3% | -17.0% | · | -23.8% | -17.5% | -15.6% | · | -21.0% | -14.1% | -12.3% | · | -14.6% | -15.1% | -16.3% | · | -11.1% |
Likidite ve Solventlik
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 13.8 | 13.1 | · | 6.7 | 9.3 | 10.9 | · | 7.9 | 13.5 | 14.9 | · | 9.4 | 10.6 | 9.4 | · | 8.7 | |
| Quick Ratio | 5.6 | 9.8 | · | 1.7 | 4.7 | 7.3 | · | 2.8 | 6.5 | 8.2 | · | 3.1 | 5.8 | 8.1 | · | 2.9 | |
| Interest Coverage | · | · | · | · | · | · | · | · | -315.8 | -282.8 | · | · | · | · | · | · |
Hisse Başına
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $3.56 | $3.80 | · | $2.80 | $3.33 | $3.80 | · | $4.29 | $5.01 | $5.57 | · | $7.20 | $8.17 | $9.39 | · | $19.02 | |
| Cash Flow / Share | · | $-0.43 | · | · | · | $-0.48 | · | · | · | $-0.66 | · | · | · | $-1.43 | · | · | |
| Cash / Share | $1.52 | $3.02 | · | $0.79 | $1.79 | $2.72 | · | $1.65 | $2.49 | $3.11 | · | $2.44 | $4.57 | $8.41 | · | $6.48 | |
| EPS (TTM) | $-2.05 | $-2.09 | · | $-2.51 | $-2.82 | $-3.01 | · | $-3.03 | $-3.29 | $-3.93 | · | $-4.53 | $-6.19 | $-8.27 | · | $-11.87 |
Değerleme (TTM)
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $0 | $0 | · | $0 | $0 | $0 | · | $0 | $0 | $0 | · | $0 | $0 | $0 | · | $0 | |
| Net Income TTM | $-207M | $-192M | · | $-167M | $-154M | $-140M | · | $-102M | $-91M | $-90M | · | $-91M | $-90M | $-91M | · | $-89M | |
| Market Cap | $1.05B | $708M | · | $481M | $378M | $287M | · | $271M | $219M | $504M | · | $51M | $105M | $93M | · | $53M | |
| P/E | -4.9 | -3.4 | · | -2.5 | -1.7 | -1.2 | · | -2.3 | -1.7 | -3.4 | · | -0.6 | -0.8 | -0.6 | · | -0.6 | |
| P/B | 2.8 | 1.9 | · | 2.2 | 1.5 | 1.0 | · | 1.6 | 1.1 | 2.4 | · | 0.4 | 0.6 | 0.5 | · | 0.4 | |
| P / Tangible Book | 2.8 | 1.9 | · | 2.2 | 1.5 | 1.0 | · | 1.6 | 1.1 | 2.4 | · | 0.4 | 0.6 | 0.5 | · | 0.4 | |
| P / Cash Flow | · | -15.0 | · | · | · | -9.0 | · | · | · | -20.0 | · | · | · | -3.3 | · | · | |
| Earnings Yield | -20.5% | -29.0% | · | -40.7% | -57.9% | -81.3% | · | -43.5% | -58.0% | -29.5% | · | -179.8% | -118.1% | -174.5% | · | -169.4% |
En son dönem solda · null değerler · olarak gösterilir
Finansal Tablolar Gelir tablosu, bilanço, nakit akışı — yıllık, son 5 yıl
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Gelir | · | · | · | $8M | $14M |
| Faaliyet Kâr Marjı % | · | · | · | -1315.2% | -530.5% |
| Net Gelir | $-174M | $-125M | $-96M | $-86M | $-72M |
| Seyreltilmiş Hisse Başı Kâr | $-1.99 | $-3.06 | $-4.83 | $-10.10 | $-10.14 |
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Cari Oran | 6.1 | 5.2 | 8.9 | 9.8 | 9.4 |
| Cari Oran | 1.8 | 2.7 | 5.1 | 6.9 | 5.0 |
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Serbest Nakit Akışı | $-157M | $-101M | $-96M | $-101M | $-79M |
Kurumsal Sahipler (13F) 164 dosya · $1.2B toplam · Tarih itibarıyla 30 Eylül 2026
Çeyreklik SEC Form 13F'lerinde bu hisse senedini tuttuklarını bildiren kurumlar. Yalnızca uzun pozisyonlar; tek bir başvuru sahibi, ayrı opsiyon bacakları için iki kez görünebilir. Büyük dengeleyici alım/satım bacakları genellikle piyasa yapımını veya korunmuş envanteri yansıtır, yönlü bir inancı değil.
Sahipler
164
Tutulan Değer
$1.2B
Yeni pozisyonlar
42
Çıkan pozisyonlar
25
Kurumsal faaliyet — Q2 2026 ve önceki çeyrek
| Yeni pozisyonlar | Çıkan pozisyonlar | Artırıldı | Azaldı | Net hisse senedi değişimi |
|---|---|---|---|---|
| 42 (+4 önceki Ç'ye göre) | 25 (+13 önceki Ç'ye göre) | 58 (+2 önceki Ç'ye göre) | 38 (-2 önceki Ç'ye göre) | +13.3M |
Q1 2026 ile karşılaştırıldı. SEC Form 13F başvuruları, çeyrek sonundan itibaren 45 gün içinde ve geç başvuranlar için kısa bir ek süre içinde tamamlanmalıdır — bu pencere içindeki çeyrekler, en son tam olarak raporlanan çifte tercih edilerek atlanır.
| Kurum | Değer | Hisse senetleri | % izlenen 13F'nin | Tür |
|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | $120.240.899 | 12.036.126 | 10,43% | Hisse senetleri |
| PERCEPTIVE ADVISORS LLC | $118.947.393 | 11.906.646 | 10,31% | Hisse senetleri |
| Bain Capital Life Sciences Investors, LLC | $97.990.102 | 9.808.819 | 8,50% | Hisse senetleri |
| Siren, L.L.C. | $76.827.146 | 7.690.405 | 6,66% | Hisse senetleri |
| BlackRock, Inc. | $69.273.136 | 6.934.248 | 6,01% | Hisse senetleri |
| FMR LLC | $68.690.808 | 6.875.957 | 5,96% | Hisse senetleri |
| ARMISTICE CAPITAL, LLC | $42.737.220 | 4.278.000 | 3,71% | Hisse senetleri |
| STATE STREET CORP | $41.711.896 | 4.175.365 | 3,62% | Hisse senetleri |
| VANGUARD CAPITAL MANAGEMENT LLC | $40.059.121 | 4.009.922 | 3,47% | Hisse senetleri |
| RTW INVESTMENTS, LP | $38.890.331 | 3.892.926 | 3,37% | Hisse senetleri |
| Deep Track Capital, LP | $35.614.969 | 3.565.062 | 3,09% | Hisse senetleri |
| FRANKLIN RESOURCES INC | $34.372.673 | 3.440.708 | 2,98% | Hisse senetleri |
| JANUS HENDERSON GROUP PLC | $28.877.004 | 4.010.695 | 2,50% | Hisse senetleri |
| CITADEL ADVISORS LLC | $28.123.069 | 2.815.122 | 2,44% | Hisse senetleri |
| Alyeska Investment Group, L.P. | $22.782.035 | 2.280.484 | 1,98% | Hisse senetleri |
| AMERIPRISE FINANCIAL INC | $22.235.593 | 2.225.783 | 1,93% | Hisse senetleri |
| Vestal Point Capital, LP | $21.578.400 | 2.160.000 | 1,87% | Hisse senetleri |
| VANGUARD GROUP INC | $19.485.969 | 3.454.959 | 1,69% | Hisse senetleri |
| Redmile Group, LLC | $19.467.463 | 1.948.695 | 1,69% | Hisse senetleri |
| GEODE CAPITAL MANAGEMENT, LLC | $19.391.710 | 1.940.824 | 1,68% | Hisse senetleri |
| GOLDMAN SACHS GROUP INC | $16.013.141 | 1.602.917 | 1,39% | Hisse senetleri |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | $15.049.995 | 1.506.506 | 1,30% | Hisse senetleri |
| DIMENSIONAL FUND ADVISORS LP | $12.645.298 | 1.266.290 | 1,10% | Hisse senetleri |
| BLAIR WILLIAM & CO/IL | $7.555.207 | 756.277 | 0,66% | Hisse senetleri |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $7.478.404 | 748.589 | 0,65% | Hisse senetleri |
| Woodline Partners LP | $6.734.019 | 674.076 | 0,58% | Hisse senetleri |
| SILVERARC CAPITAL MANAGEMENT, LLC | $6.677.816 | 668.450 | 0,58% | Hisse senetleri |
| Birchview Capital, LP | $6.655.298 | 666.196 | 0,58% | Hisse senetleri |
| NORTHERN TRUST CORP | $6.030.434 | 603.647 | 0,52% | Hisse senetleri |
| MOORE CAPITAL MANAGEMENT, LP | $6.028.685 | 603.472 | 0,52% | Hisse senetleri |
| BANK OF AMERICA CORP /DE/ | $5.235.779 | 524.102 | 0,45% | Hisse senetleri |
| Monashee Investment Management LLC | $4.995.000 | 500.000 | 0,43% | Hisse senetleri |
| VANGUARD FIDUCIARY TRUST CO | $4.942.353 | 494.730 | 0,43% | Hisse senetleri |
| Point72 Asset Management, L.P. | $4.475.600 | 448.008 | 0,39% | Hisse senetleri |
| STEMPOINT CAPITAL LP | $3.584.212 | 358.780 | 0,31% | Hisse senetleri |
| Boxer Capital Management, LLC | $2.997.000 | 300.000 | 0,26% | Hisse senetleri |
| JPMORGAN CHASE & CO | $2.667.443 | 281.673 | 0,23% | Hisse senetleri |
| Ally Bridge Group (NY) LLC | $2.557.030 | 255.959 | 0,22% | Hisse senetleri |
| MORGAN STANLEY | $2.549.403 | 255.195 | 0,22% | Hisse senetleri |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $2.441.566 | 244.401 | 0,21% | Hisse senetleri |
| Bank of New York Mellon Corp | $2.429.105 | 243.154 | 0,21% | Hisse senetleri |
| J. Goldman & Co LP | $2.419.218 | 242.164 | 0,21% | Hisse senetleri |
| Nuveen, LLC | $2.414.004 | 241.642 | 0,21% | Hisse senetleri |
| D. E. Shaw & Co., Inc. | $2.225.662 | 222.789 | 0,19% | Hisse senetleri |
| UBS Group AG | $1.881.587 | 188.347 | 0,16% | Hisse senetleri |
| ALGERT GLOBAL LLC | $1.872.316 | 187.419 | 0,16% | Hisse senetleri |
| WELLINGTON MANAGEMENT GROUP LLP | $1.851.797 | 185.365 | 0,16% | Hisse senetleri |
| Balyasny Asset Management L.P. | $1.780.747 | 178.253 | 0,15% | Hisse senetleri |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $1.628.740 | 163.037 | 0,14% | Hisse senetleri |
| Apis Capital Advisors, LLC | $1.598.400 | 160.000 | 0,14% | Hisse senetleri |
Aktivistler ve %5+ sahipler 4 pozisyon
SEC Çizelge 13D dosyalayan yatırımcılar — ihraççı üzerinde nüfuz etme niyetiyle %5'in üzerinde faydalı sahiplik (aktivist hisseler, yönetim kurulu kampanyaları, M&A). Her satır, o başvuru sahibinin pozisyonunun bilinen en son durumunu gösterir.
| Başvuru sahibi | Dosyalandı | Hisse | Durum | Amaç | Başvuru |
|---|---|---|---|---|---|
| Perceptive Advisors LLC, Joseph Edelman, Perceptive Life Sciences Master Fund, Ltd., Perceptive Xontogeny Venture Fund, LP ×11 başvurular | 14 Ağustos 2026 | 11,20% | Değişiklik | · | SEC |
| RA Capital Management, L.P., Peter Kolchinsky, Rajeev Shah, RA Capital Healthcare Fund, L.P. ×12 başvurular | 24 Haziran 2026 | 11,90% | Değişiklik | · | SEC |
| BCLS SB Investco, LP, Bain Capital Life Sciences Fund II, L.P., BCLS II Investco, LP, BCIP Life Sciences Associates, LP, BCLS II Equity Opportunities, LP, Bain Capital Life Sciences Opportunities IV, L.P. ×12 başvurular | 10 Mart 2026 | 8,80% | Değişiklik | · | SEC |
| RA Capital Management, LLC, Peter Kolchinsky ×2 başvurular | 30 Temmuz 2019 | · | İlk başvuru | Pasif yatırım | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Şirket yöneticileri 29 içeriden öğrenenler · 13 yöneticiler · 14 yönetim kurulu üyeleri
| İçeriden Öğrenen | Rol | Son işlem | Sahip olunan hisse senetleri | Alımlar 12ay | Satışlar 12ay | Net 12ay |
|---|---|---|---|---|---|---|
| Alexander Cumbo | President and CEO | 29 Ocak 2026 A | 235.405 | 0 | 4 | $-983.959 |
| Kevin Tan | CFO & Treasurer | 29 Ocak 2026 A | 99.422 | 0 | 4 | $-329.544 |
| Jennifer Lynn Ziolkowski | CFO, Treasurer & Asst. Secy | 27 Ocak 2021 M | 335.636 | 0 | 0 | $0 |
| David T Howton | Chief Operating Officer | 29 Ocak 2026 A | 105.077 | 0 | 4 | $-433.595 |
| Pedro Alvaro Amorrortu | Chief Operating Officer | 23 Ocak 2019 A | 162.746 | 0 | 0 | $0 |
| Gabriel Brooks | Chief Medical Officer | 29 Ocak 2026 A | 89.466 | 0 | 3 | $-280.978 |
| Paul Herzich | Chief Technology Officer | 29 Ocak 2026 A | 72.638 | 0 | 4 | $-274.125 |
| Jessie Hanrahan | Chief Regulatory Officer | 29 Ocak 2026 A | 74.318 | 0 | 4 | $-297.374 |
| Jennifer Marlowe | CSO | 13 Şubat 2024 A | 6.998 | 0 | 0 | $0 |
| Carl Ashley Morris | Chief Scientific Officer | 27 Ocak 2023 M | 19.760 | 0 | 0 | $0 |
| Erin Powers Brennan | Chief Legal Officer, Secretary | 02 Mayıs 2022 A | · | 0 | 0 | $0 |
| Lynette Herscha | Chief Legal Officer | 27 Temmuz 2020 M | 160.859 | 0 | 0 | $0 |
| Jorge Armando Quiroz | Chief Medical Officer | 23 Ocak 2019 A | 228.092 | 0 | 0 | $0 |
| Ian F Smith | Yönetim kurulu üyesi | 02 Temmuz 2026 M | 138.145 | 0 | 0 | $0 |
| Clare Kahn | Yönetim kurulu üyesi | 10 Haziran 2026 A | 2.960 | 0 | 0 | $0 |
| Georgia Keresty | Yönetim kurulu üyesi | 10 Haziran 2026 A | · | 0 | 0 | $0 |
| Lynne Marie Sullivan | Yönetim kurulu üyesi | 10 Haziran 2026 A | · | 0 | 0 | $0 |
| Ilan Ganot | Yönetim kurulu üyesi | 10 Haziran 2026 A | 27.474 | 0 | 5 | $-82.352 |
| Adam Leo Stone | Yönetim kurulu üyesi | 10 Haziran 2026 A | · | 0 | 0 | $0 |
| Martin I Freed | Yönetim kurulu üyesi | 10 Haziran 2026 A | 53.763 | 0 | 0 | $0 |
| Sukumar Nagendran | Yönetim kurulu üyesi | 10 Haziran 2026 A | 34.258 | 0 | 0 | $0 |
| Adam Koppel | Yönetim kurulu üyesi | 11 Ocak 2024 A | 4.034.582 | 0 | 0 | $0 |
| Robert Luther Huffines | Yönetim kurulu üyesi | 13 Aralık 2022 A | · | 0 | 0 | $0 |
| Rajeev Shah | Yönetim kurulu üyesi | 16 Haziran 2021 A | 8.709.882 | 0 | 0 | $0 |
| Matthew Bennett Arnold | Yönetim kurulu üyesi | 10 Aralık 2020 A | 3.933.429 | 0 | 0 | $0 |
| Juan Andrey Zarur | Yönetim kurulu üyesi | 02 Ocak 2020 A | 10.189 | 0 | 0 | $0 |
| Boxer Capital, LLC | 10% sahip | 28 Mart 2019 S | 3.473.272 | 0 | 0 | $0 |
| Gilad David Hayeem | 10% sahip | 22 Ağustos 2018 G | 1.948.991 | 0 | 0 | $0 |
| Joel Solomon Zev Schneider | · | 14 Mart 2022 S | 236.270 | 0 | 0 | $0 |
SEC Form 3/4/5 başvurularından yöneticiler; net = yalnızca açık piyasa Alış/Satış
ETF sahipliği 29 ETF'ler tarafından tutuluyor
Ağırlık yalnızca doğrudan öz sermaye varlıklarını (N-PORT) yansıtır; kaldıraçlı veya türev tabanlı fonlar gösterilmeyen ek swap pozisyonlarına sahip olabilir.
| Fon | Ağırlık | Birimler | Tarih itibarıyla | Kaynak |
|---|---|---|---|---|
| BBC · ETFis Series Trust I | 0,76% | 43.531 NS | 31 Temmuz 2026 | N-PORT |
| IBRN · iShares Trust | 0,74% | 6.132 SH | 11 Eylül 2026 | Günlük |
| IWC · iShares Trust | 0,17% | 267.842 SH | 11 Eylül 2026 | Günlük |
| LABU · Direxion Shares ETF Trust | 0,14% | 87.747 NS | 31 Temmuz 2026 | N-PORT |
| IBB · iShares Trust | 0,05% | 598.147 SH | 11 Eylül 2026 | Günlük |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 0,05% | 7.592 SH | 01 Ekim 2026 | Günlük |
| PWS · Pacer Funds Trust | 0,04% | 1.199 NS | 31 Temmuz 2026 | N-PORT |
| VFMO · VANGUARD WELLINGTON FUND | 0,03% | 50.645 SH | 19 Ağustos 2026 | Günlük |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0,03% | 35.267 SH | 19 Ağustos 2026 | Günlük |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,03% | 102.425 SH | 01 Ekim 2026 | Günlük |
| IWM · iShares Trust | 0,02% | 2.015.412 SH | 11 Eylül 2026 | Günlük |
| IWO · iShares Trust | 0,02% | 359.257 SH | 11 Eylül 2026 | Günlük |
| RSSL · Global X Funds | 0,02% | 37.599 NS | 31 Temmuz 2026 | N-PORT |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,02% | 452.695 SH | 19 Ağustos 2026 | Günlük |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,02% | 41.246 SH | 19 Ağustos 2026 | Günlük |
| DFAS · Dimensional ETF Trust | 0,02% | 293.621 NS | 31 Temmuz 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0,01% | 773.750 SH | 19 Ağustos 2026 | Günlük |
| VHT · VANGUARD WORLD FUND | 0,01% | 163.029 SH | 19 Ağustos 2026 | Günlük |
| DXUV · Dimensional ETF Trust | 0,00% | 2.475 NS | 31 Temmuz 2026 | N-PORT |
| DFSU · Dimensional ETF Trust | 0,00% | 7.422 NS | 31 Temmuz 2026 | N-PORT |
| DCOR · Dimensional ETF Trust | 0,00% | 10.716 NS | 31 Temmuz 2026 | N-PORT |
| DFAU · Dimensional ETF Trust | 0,00% | 19.273 NS | 31 Temmuz 2026 | N-PORT |
| DFAC · Dimensional ETF Trust | 0,00% | 77.462 NS | 31 Temmuz 2026 | N-PORT |
| ITOT · iShares Trust | 0,00% | 111.903 SH | 11 Eylül 2026 | Günlük |
| IWV · iShares Trust | 0,00% | 24.592 SH | 11 Eylül 2026 | Günlük |
| DFUS · Dimensional ETF Trust | 0,00% | 20.397 NS | 31 Temmuz 2026 | N-PORT |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 3.148.576 SH | 19 Ağustos 2026 | Günlük |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 5.707 SH | 19 Ağustos 2026 | Günlük |
| IWN · iShares Trust | · | 371.548 SH | 11 Eylül 2026 | Günlük |
SLDB Analist Uzlaşması Boğa ve ayı analist görüşleri, 12 aylık fiyat hedefi, yukarı yönlü potansiyel
derecelendirme · 19 analist
AL
Medyan hedef
$18.00
+162,8%
8 42,1%
Güçlü Al
10 52,6%
Al
1 5,3%
Tut
0 0,0%
Sat
0 0,0%
Güçlü Sat
12 Aylık Fiyat Hedefi
13 analist · 2026-09-28Ortalama hedef $18.62 +171,8%
← Tüm hedeflerin altında
Mevcut fiyat $6.85
Düşük$11.00
Ortalama$18.62
Yüksek$26.00
Akran karşılaştırması (GICS alt sektörü) Anahtar metrikler sektördeki benzerlerine karşı
Mali yıl bazında, fiyatlar her şirketin son mali yıl kapanışına göredir.
| Hisse Sembolü | Piyasa Değeri | P/E | Gelir YoY | Net Kar Marjı | ROE | Brüt Kar Marjı |
|---|---|---|---|---|---|---|
| SLDB | $445M | -2.8 | · | · | -79.5% | · |
| DSGN | $567M | -7.7 | · | · | -32.8% | · |
| GERN | $845M | -10.2 | -60.2% | · | -34.4% | · |
| FDMT | $432M | -3.1 | 230194.6% | -164.4% | -30.2% | · |
| GYRE | $645M | 353.0 | 10.2% | 8.5% | 11.7% | · |
| ACHV | · | -4.0 | · | · | · | · |
| FTH | · | · | · | · | · | · |
| VSTM | $600M | -2.6 | 209.1% | -677.6% | -449.2% | · |
| OLMA | $2.03B | -13.4 | · | · | -39.4% | · |
| NVCT | $194M | -5.7 | · | · | -149.9% | · |
Metriklerim Kişisel izleme listeniz — Tam Temeller'den seçilen satırlar
Sizin için önemli olan metrikleri seçin — Yukarıdaki Tam Temeller bölümündeki herhangi bir satırın yanındaki + işaretine tıklayın.
Seçiminiz kaydedildi ve tüm hisse senetlerinde sizinle birlikte gelir.
Kaynak: SEC 10-Q dosyalandı Ağu 6, 2026